Literature DB >> 1396748

Antibiotic sensitivity of the Bacteroides fragilis group in Europe. European Study Group.

I Phillips1, A King, C E Nord, B Hoffstedt.   

Abstract

Rates of resistance to 12 antibiotics were determined for 1,289 isolates of Bacteroides fragilis group submitted in 1988-1989 by 22 laboratories in 15 European countries. There was no resistance to metronidazole (breakpoint 8 mg/l) and only one isolate was resistant to chloramphenicol (breakpoint 8 mg/l). Resistance was uncommon for imipenem (0.3% at greater than 4 mg/l), amoxicillin/clavulanate (1% at greater than 8 mg/l), cefoxitin (3% at greater than 32 mg/l), mezlocillin (6% at greater than 64 mg/l) and clindamycin (9% at greater than 4 mg/l). Resistance was the rule for ampicillin (93% at greater than 4 mg/l), ciprofloxacin (56% at greater than 4 mg/l) and tetracycline (64% at greater than 4 mg/l). Bacteroides fragilis, the commonest species, was generally the most sensitive: resistance of this organism was uncommon for cefotetan (4% at greater than 32 mg/l) and ceftazidime (12% at greater than 32 mg/l) to which the other species were more often resistant. There were small but significant differences between laboratories and countries for many of the antibiotics. Regionally the most striking differences were for clindamycin where resistance in Bacteroides fragilis was most common in the South and for tetracycline where resistance in Bacteroides fragilis, Bacteroides thetaiotaomicron and Bacteroides uniformis was least common in the North.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1396748     DOI: 10.1007/bf01962068

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987.

Authors:  N A Cornick; G J Cuchural; D R Snydman; N V Jacobus; P Iannini; G Hill; T Cleary; J P O'Keefe; C Pierson; S M Finegold
Journal:  J Antimicrob Chemother       Date:  1990-06       Impact factor: 5.790

2.  Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group.

Authors:  G J Cuchural; F P Tally; N V Jacobus; T Cleary; S M Finegold; G Hill; P Iannini; J P O'Keefe; C Pierson
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

3.  Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology.

Authors:  K E Aldridge; H M Wexler; C V Sanders; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

4.  Survey of Bacteroides fragilis susceptibility patterns in France.

Authors:  J Breuil; C Burnat; O Patey; A Dublanchet
Journal:  J Antimicrob Chemother       Date:  1989-07       Impact factor: 5.790

5.  Increasing resistance of Bacteroides fragilis group strains to metronidazole in Spain between 1977 and 1982.

Authors:  M V Borobio; A Pascual; E J Perea
Journal:  Eur J Clin Microbiol       Date:  1984-04       Impact factor: 3.267

Review 6.  Evolution in antibiotic susceptibility of Bacteroides fragilis group strains in France based on periodic surveys.

Authors:  L Dubreuil; M Derriennic; A Sedallian; C Romond; A L Courtieu
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

7.  Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.

Authors:  P C Appelbaum; S K Spangler; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

8.  Survey of anaerobic susceptibility patterns in Canada.

Authors:  A M Bourgault; G K Harding; J A Smith; G B Horsman; T J Marrie; F Lamothe
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

9.  Epidemiology of clindamycin resistance in the Bacteroides fragilis group.

Authors:  M Reig; M G Campello; F Baquero
Journal:  J Antimicrob Chemother       Date:  1984-12       Impact factor: 5.790

10.  Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation.

Authors:  G J Cuchural; F P Tally; N V Jacobus; K Aldridge; T Cleary; S M Finegold; G Hill; P Iannini; J P O'Keefe; C Pierson
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

View more
  8 in total

1.  Comparative in vitro activity of Ro 40-6890, Ro 41-3399, and other antimicrobial agents against anaerobic bacteria.

Authors:  J Wüst; U Hardegger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

2.  In vitro susceptibility to selected antibiotics in bacteria of the Bacteroides fragilis group.

Authors:  D Chmelar
Journal:  Folia Microbiol (Praha)       Date:  2009-10-14       Impact factor: 2.099

3.  Susceptibility patterns and characterization of beta-lactamases in clinical isolates of Bacteroides fragilis.

Authors:  P Mastrantonio; P Spigaglia; A Sebastianelli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-06       Impact factor: 3.267

Review 4.  Anaerobic infections: update on treatment considerations.

Authors:  Elisabeth Nagy
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

Review 5.  Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections.

Authors:  J A Balfour; H M Bryson; R N Brogden
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

6.  In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections.

Authors:  G P Bongaerts; J A Hoogkamp-Korstanje
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

7.  Characteristics of pyogenic odontogenic infection in patients attending Mulago Hospital, Uganda: a cross-sectional study.

Authors:  Richard Kityamuwesi; Louis Muwaz; Arabat Kasangaki; Henry Kajumbula; Charles Mugisha Rwenyonyi
Journal:  BMC Microbiol       Date:  2015-02-25       Impact factor: 3.605

8.  Phenotypic and genotypic antimicrobial resistance in clinical anaerobic isolates from India.

Authors:  Anshul Sood; Pallab Ray; Archana Angrup
Journal:  JAC Antimicrob Resist       Date:  2021-04-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.